Epitalon half-life is often cited at just a few minutes. Learn what research says about how fast the peptide clears, dosing, and what it means.
Epitalon's half-life is widely cited as roughly 2 to 5 minutes in blood plasma, because circulating enzymes called proteases break the tetrapeptide apart almost as soon as it enters the bloodstream. That figure comes from animal and laboratory work, not from a formal human pharmacokinetic trial, so it should be treated as an estimate rather than a measured constant. The practical takeaway is that Epitalon clears quickly, and the effects people attribute to it are generally explained by downstream changes in gene activity rather than by the peptide itself lingering in the body.
What Is Epitalon?
Epitalon — also spelled Epithalon, and known by its sequence AEDG — is a synthetic four-amino-acid peptide developed by the Russian researcher Vladimir Khavinson. It was modeled on epithalamin, a peptide preparation extracted from the pineal gland, and most of the research on it has come out of Russia and Eastern Europe.
The central claim attached to Epitalon is that it activates telomerase, the enzyme that maintains the protective caps on the ends of chromosomes. Cell studies have reported increased telomerase activity after Epitalon exposure.
That work has never been confirmed in a large randomized human trial. The epitalon wikipedia entry and most vendor pages tend to repeat the same small set of older references rather than adding new data.
How Long Does Epitalon Stay Active in the Body?
A half-life is the time required for half of a dose to be eliminated. For peptides, that process is driven mostly by enzymes in the blood, liver, and kidneys, and very short peptides are especially vulnerable to rapid breakdown.
Epitalon is only four amino acids long, which makes it an easy target. It is generally described as having one of the shortest half-lives of any peptide used in the longevity space.
| Compound | Reported half-life | Usual route | What it means in practice |
|---|---|---|---|
| Epitalon (AEDG) | About 2–5 minutes | Subcutaneous injection, intranasal | Cleared almost immediately; proposed benefits are downstream |
| Thymalin | Minutes to a few hours | Injection | Frequently studied alongside Epitalon |
| PT-141 (bremelanotide) | About 2.7 hours | Subcutaneous injection | FDA-approved drug; figure taken from the product label |
| Glutathione | Under a few minutes in plasma | IV, oral, topical | Very short plasma residence time |
Side-by-side comparisons make the contrast obvious. The pt-141 half-life of about 2.7 hours reflects a molecule engineered to resist degradation long enough to reach receptors in the brain, while Epitalon is broken down before it can accumulate.
Why a Short Half-Life Doesn't Mean a Short Effect
Peptides act as signals, not as drugs that must stay above a certain blood level to work. A signaling molecule can be undetectable in plasma within minutes while the cellular response it triggered lasts far longer.
Khavinson's group has proposed that short peptides enter cells and bind directly to DNA, influencing the expression of specific genes. If that model is correct, the measurable presence of Epitalon in blood would be a poor predictor of its biological activity.
Mainstream pharmacologists are not convinced by the direct DNA-binding model, and no independent group has confirmed it in humans. This debate is the main reason researchers do not chase Epitalon blood levels the way they would with a conventional medication.
How Epitalon Is Typically Dosed
Because the half-life is so short, dosing protocols generally rely on repeated exposure rather than on a single long-acting dose. Common epitalon dosage injection regimens described in the gray literature call for 5 to 10 mg per day for 10 to 20 days, usually repeated once or twice a year.
Some protocols split the daily amount into two smaller injections to spread exposure across the day. There is no published evidence that splitting the dose improves results.
Intranasal use is also described, and some users combine it with Thymalin epitalon protocols, in which the two peptides are given together in short courses. No standardized dosing exists for any of these approaches.
Reconstitution, Storage, and Handling
Epitalon peptide reconstitution is usually done with bacteriostatic water. Add the diluent slowly down the inside wall of the vial instead of aiming it at the powder, and swirl gently rather than shaking, since agitation can damage the peptide.
Storage matters for stability, but it is separate from half-life in the body:
- Lyophilized (powder) vials: keep frozen or refrigerated, protected from light, for long-term storage.
- Reconstituted vials: refrigerate at around 2–8 °C and use within a few weeks.
- Avoid repeated temperature swings and never refreeze a reconstituted solution.
A peptide that is chemically degraded in the vial may be inactive before it is ever injected, which is a different problem from a short biological half-life.
Safety, Legality, and Realistic Expectations
Epitalon is not FDA-approved for human use in the United States. It is legally sold only as a research chemical, which means products are not verified for purity, sterility, or accurate dosing by any regulator.
Small studies have reported few adverse effects, but those studies were short and limited in size. Injection brings the usual risks of contamination, dosing errors, and injection-site reactions.
No peptide has been proven to extend human lifespan. Anyone considering Epitalon should discuss it with a licensed healthcare professional rather than relying on marketing claims.
Frequently Asked Questions
How long does Epitalon stay in your system?
Epitalon is commonly reported to have a plasma half-life of about 2 to 5 minutes, meaning most of a dose is broken down almost immediately by blood enzymes. Within roughly half an hour, little or none of the intact peptide is expected to remain in circulation. That estimate comes from animal and lab data, not from a published human pharmacokinetic study.
How often should Epitalon be injected?
Protocols described in the gray literature typically use 5 to 10 mg per day for 10 to 20 consecutive days, repeated once or twice a year. Because the half-life is so short, the daily dose is sometimes split into two injections. No standardized or officially approved dosing schedule exists.
Does Epitalon actually extend lifespan?
Epitalon has been reported to increase lifespan in some rodent studies conducted by its original research group, but those findings have not been replicated in humans. No controlled human trial has shown that Epitalon extends lifespan or reverses aging. It is not FDA-approved for any human use.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.